Evaluation of Non-Invasive Assessment for Post RFAL Procedure Monitoring Using the Nanowear Wearable Multiple Sensor Vest
Sponsor: Nanowear Inc.
Trial Details
| Condition | Elective Surgical Procedures |
| Intervention | Observational Study: No intervention |
| Status | Completed |
| Participants | 44 |
| Est. Completion | 30 Apr 2021 |
| Last Updated | 9 Apr 2026 |
Primary Outcome
Subject assessment of comfort and compliance
Eligibility Criteria
Inclusion Criteria
Inclusion Criteria: * Signed informed consent to participate in the study. * Female and male subjects, at least 18 years of age at the time of enrolment * The patient is scheduled to undergo BodyTite and/or FaceTite procedures. * The patients should be willing to comply with the study procedure and schedule. Exclusion Criteria: * Pacemaker or internal defibrillator, or any other active electrical implant anywhere in the body. * Pregnancy and nursing. * Subject unwilling or unable to comply with wearing the Nanowear System 12 hours daily for at least 48 hours Up to 7 days * As per the practitioner's discretion, refrain from treating any condition that might make it unsafe for the patient
Trial Sites
Countries
This content is for educational purposes for healthcare professionals only and does not constitute clinical advice. Clinical decisions should be based on individual patient assessment, current guidelines, and appropriate specialist consultation. Editorial Standards · Privacy Policy · Terms of Service